#United States #Scottsdale #Venture Capital #Xcellerant Ventures #Jetstream Fund

Xcellerant Ventures Launches Jetstream Venture Fund

On October 9, 2025, Xcellerant Ventures (XVC) unveiled its latest initiative, the Jetstream Venture Fund, a groundbreaking interval fund designed to broaden access to venture capital-style investments. Traditionally confined to institutional players or the affluent elite, this fund opens the doors of opportunity to a wider swath of professionals, requiring a minimum investment of only $20,000.

Breaking New Ground in Investment Accessibility

The Jetstream Venture Fund is tailored for those seeking an easier entry into the venture capital space without the substantial financial barriers commonly associated with this realm. Instead of the usual minimum investments ranging between $250,000 to $500,000, Jetstream lowers the entry point significantly, allowing more individuals to participate in venture investing. Additionally, this fund benefits investors with semi-annual withdrawal options and offers an evergreen structure, allowing them to remain engaged throughout the full growth cycle of their investments.

A unique aspect of the Jetstream model is its profit-sharing structure; rather than employing carried interest, it utilizes a straightforward management fee of 2.9%, alongside operating expenses, ensuring that investors can retain a larger share of their profits.

Leadership with Proven Expertise

Steering this pioneering venture is Dr. John Shufeldt, MD, JD, MBA, a highly regarded physician and entrepreneur who has an impressive track record in the healthcare sector. He is known for founding and scaling successful companies, including NextCare Urgent Care and MeMD, which was acquired by Walmart Health. Dr. Shufeldt emphasizes that Jetstream was created to bridge the gap in investment access for those historically overlooked in this high-performing asset class. He states, “Early-stage venture capital has been one of the best performing asset classes in the U.S. for decades, yet many professionals have been left out.”

Joining him on the leadership team are Chris Yoo, PhD, who brings a background in bioinformatics and commercialization, Doug Sylvester, JD, LLM, noted for his expertise at the interface of law and innovation, and Mike Shufeldt, MBA, an Air Force veteran and established healthcare entrepreneur. This team combines their extensive operational experience with their venture investment knowledge, offering a unique perspective that enhances Jetstream's potential.

Focusing on MedTech, BioTech, and HealthTech

While Jetstream is a generalist fund, its leadership sees significant opportunity within the MedTech, BioTech, and HealthTech sectors. This focus aligns with the extensive experience and networks the team brings to the table, enabling them to identify valuable companies that are ready to make substantial impacts in these fields. Dr. Yoo notes, “Unlike many venture firms, we have hands-on experience within the industries we invest in, allowing us to grasp the challenges and opportunities that exist.”

An Invitation to a New Era of Investing

Jetstream Venture Fund aims to position itself at the intersection of innovative healthcare solutions and early-stage company growth. As they seek out disruptive innovations that can scale effectively, Jetstream is prepared to invite a broader audience of investors to engage in venture capital opportunities that were once confined to a select few.

Sylvester adds, “We are at the forefront of a public-private trend and want to extend an invitation for everyone interested in early-stage VC investing to closely examine our Fund.”

About Xcellerant Ventures

Based in Phoenix, Arizona, Xcellerant Ventures specializes in investing in early and seed-stage startups focusing on HealthTech, MedTech, and BioTech. The firm is dedicated to supporting transformational companies through their growth and regulatory challenges. For more information, interested parties can visit Xcellerant Ventures.

Conclusion

With the Jetstream Venture Fund, Xcellerant Ventures not only aims to democratize access to venture capital investments but also seeks to create a significant impact in the healthcare and technology sectors. The fund’s groundbreaking approach positions it as a key player in reshaping the landscape of investment accessibility.